Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BISS: Botox vs Surgery in Acquired Esotropia
NCT03459092Phase 3Completed
- Sponsor
- Insel Gruppe
- Start
- Aug 2018
- Primary completion
- Jul 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 2
01
Overview
A Phase 3 trial of botulinum toxin type A in Acquired esotropia, sponsored by Insel Gruppe. Started Aug 2018; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
Acquired esotropia
Beyond the preview
Go deeper on NCT03459092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03459092.